Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > 5 long years
View:
Post by boazklinghorn on Nov 23, 2021 11:00am

5 long years

Y'all crack me up. Poor old OBG. For years it was the hero formulation and boom overnight YBG is the the star and OBG is dead. And thus we can start another 2 or 3 year odessey of hopes and dreams. 
FUN FACT;  Billion dollar start ups are built in the time it takes Gilles to put on his pants in the morning. Wake the hell up. 
Oats, this comes down to you buddy, you told me you were waiting. Now is the time, we can easily get 25% or 30% of the shares in a block now and get some change.
Comment by prophetoffacts on Nov 23, 2021 11:15am
This post has been removed in accordance with Community Policy
Comment by boazklinghorn on Nov 23, 2021 12:00pm
Hey Proph the world is awash in YBG,  but just like with OBG the PGX process opens new doors...or does it? YBG is a known immune booster but we dont want that angle do we. We dont want to compete in the market we want a pharma grad pill for a special purpose.. Is any of this sounding familiar.. At least for OBG there was reason to believe based on anecdotal evidence that it would work. With ...more  
Comment by prophetoffacts on Nov 23, 2021 12:14pm
This post has been removed in accordance with Community Policy
Comment by hoffbag on Nov 23, 2021 12:27pm
If Ceapro inhalable YBG had potential or value to the extent discussed, we would be collaborating with a pharma already.  Studies have already been done.   As I remarked on the OBG/MHI "pharma pill" adventure and was eventually proved correct.... why are we wasting time and money on trials and not going to the nutraceutical market NOW.  End result is neither a nutra ...more  
Comment by prophetoffacts on Nov 23, 2021 12:35pm
This post has been removed in accordance with Community Policy
Comment by hoffbag on Nov 23, 2021 12:46pm
Excellent..... Where is Ceapro mentioned?  
Comment by prophetoffacts on Nov 23, 2021 12:42pm
This post has been removed in accordance with Community Policy
Comment by prophetoffacts on Nov 23, 2021 11:24am
This post has been removed in accordance with Community Policy
Comment by boazklinghorn on Nov 23, 2021 11:35am
You miss my point entirley. The problem is the facility with which Gilles drops a two year project and starts another. OBG was a know lowerer of LDL which at least made the idea of a OBG pill a worthy bet. Everthing YBG is hypothetical and thus a much lower value proposition despite the relentless cheerleading by Gilles. He/we missed the lay up and we are now hoping to drain a buzzer beating three ...more  
Comment by prophetoffacts on Nov 23, 2021 11:56am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities